Nonhereditary heterotopic ossification: Implications for injury, arthropathy, and aging

Clinical Reviews in Bone and Mineral Metabolism

Volumn 3, Issue 3-4, 2005, Pages 261-266

  Pignolo, Robert J ^a,b   Foley, Kristin L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Aging; Arthopathy; Heterotopic ossification; Injury

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; ETIDRONIC ACID; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

AGE DISTRIBUTION; AGING; ARTHROPATHY; ARTICLE; ATHEROSCLEROSIS; CLINICAL FEATURE; DECUBITUS; DEEP VEIN THROMBOSIS; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DRUG MECHANISM; FRACTURE HEALING; GASTROINTESTINAL DISEASE; HETEROTOPIC OSSIFICATION; HUMAN; INFLAMMATION; INJURY; KIDNEY DISEASE; NONHEREDITARY HETEROTOPIC OSSIFICATION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERIARTICULAR JOINT DISEASE; PERIOPERATIVE PERIOD; PROPHYLAXIS; SIDE EFFECT; SURGICAL TECHNIQUE; URINARY TRACT INFECTION; VALVULAR HEART DISEASE;

EID: 25844492010     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1385/BMM:3:3-4:261     Document Type: Article

References (29)

1. Neal B, Gray H, MacMahon S, Dunn L. 2002 Incidence of heterotopic bone formation after major hip surgery. ANZ J Surg 72:808-821.
2. Garland DE, Blum CE, Waters RL. 1980 Periarticular heterotopic ossification in head-injured adults. Incidence and location. J Bone Joint Surg Am 62:1143-1146.
3. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. 2001 Bone formation and inflammation in cardiac valves. Circulation 103:1522-1528.
4. Chan ED, Morales DV, Welsh CH, McDermott MT, Schwarz MI. 2002 Calcium deposition with or without bone formation in the lung. Am J Resp Crit Care Med 165:1654-1669.
5. Ackerman LV. 1958 Extra-osseous localized non-neoplastic bone and cartilage formation (so-called myositis ossificans): clinical and pathological confusion with malignant neoplasms. J Bone Joint Surg Am 40-A:279-298.
6. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. 1994 TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 93:2106-2113.
7. Mohler ER 3rd, Chawla MK, Chang AW, et al. 1999 Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 8:254-260.
8. Bidner SM, Rubins IM, Desjardins JV, Zukor DJ, Goltzman D. 1990 Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J Bone Joint Surg Am 72:1144-1149.
9. Kurer MH, Khoker MA, Dandona P. 1992 Human osteoblast stimulation by sera from paraplegic patients with heterotopic ossification. Paraplegia 30:165-168.
10. Renfree KJ, Banovac K, Hornicek FJ, Lebwohl NH, Villanueva PA, Nedd KJ. 1994 Evaluation of serum osteoblast mitogenic activity in spinal cord and head injury patients with acute heterotopic ossification. Spine 19:740-746.
11. Ekelund A, Brosjö O, Nilsson, OS. 1991 Experimental induction of heterotopic bone. Clin Orthop Rel Res 263:102-112.
12. Kan L, Hu M, Gomes WA, Kessler JA. 2004 Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Am J Pathol 165:1107-1115.
13. Glaser DL, Economides AN, Wang L, et al. 2003 In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am 85-A:2332-2342.
14. Scutt A, Bertram P. 1995 Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors. J Bone Miner Res 10:474-487.
15. Schurch, B, Capaul, M, Vallottom, MB, Rossier, AB 1997 Prostaglandin E2 measurements: their value in the early diagnosis of heterotopic ossification in spinal cord injury patients. Arch Phys Med Rehabil 78:687-691.
16. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. 2004 Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864.
17. Phillips RJ, Burdick MD, Hong K, et al. 2004 Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114:438-446.
18. Pignolo, RJ, Billings, PC, Suda, RK, et al. 2004 Circulating osteogenic cells in heterotopic bone formation. J Bone Min Res 19:S35.
19. Kaplan FS, Glaser DL, Hebela N, Shore EM. 2004 Heterotopic ossification. J Am Acad Orthop Surg 12:116-125.
20. Neal B. 2003 Effects of heterotopic bone formation on outcome after hip arthroplasty. ANZ J Surg 73:422-426.
21. Barrack RL, Brumfield CS, Rorabeck CH, Cleland D, Myers L. 2002 Heterotopic ossification after revision total knee arthroplasty. Clin Orthop 404:208-213.
22. Edwards JE. 1961 Calcific aortic stenosis: pathologic features. Mayo Clin Proc 36:444-451.
23. Lane JE, Dean RJ, Foulkes GD, Chandler PW. 2002 Idiopathic heterotopic ossification in the intensive care setting. Postgrad Med J 78:494-495.
24. Neal BC, Rodgers A, Clark T, et al. 2000 A systematic survey of 13 randomized trials of non-steroidal antiinflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand 71:122-128.
25. Banovac K. 2003 The effect of etidronate on late development of heterotopic ossification after spinal cord injury. J Spinal Cord Med. 23:40-44.
26. Cornes PG, Shahidi M, Glees JP. 2002 Heterotopic bone formation: irradiation of high risk patients. Br J Radiol 75:448-452.
27. Lo TC, Healy WL. 2001 Re-irradiation for prophylaxis of heterotopic ossification after hip surgery. Br J Radiol 74:503-506.
28. Gear AJ, Buckley C, Kaplan F, Vanbeek A. 2004 Multifactorial refractory heterotopic ossification. Ann Plast Surg 52:319-324.
29. Carabello BA. 2002 Clinical practice. Aortic stenosis. N Engl J Med 346:677-682.